GE HealthCare

Despite GE HealthCare's underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

CHICAGO, June 09, 2026--GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA.

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthesia-delivery-systems-recall-ge-healthcare-issues-correction-certain-carestations-due-risk

GEHC wins FDA clearance for AI-powered radiation planning software, adding new clinical models and a pathway for faster future updates.

DexCom has lagged behind the Dow Jones over the past year, yet analysts remain highly bullish about the stock’s outlook.

Some investors may be wondering whether GE HealthCare Technologies at around US$63.81 is starting to look like value, or if the stock still has work to do before it feels compelling. The share price has risen about 1.…

GE HealthCare Technologies (NasdaqGS:GEHC) has received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 auto-contouring software for radiation therapy planning. The software introduces an AI-ready framework in…